Abstract
Systemic lupus erythematosus (SLE) is a systemic immunodisease of the connective tissue in which mainly the skin, joints, kidneys, nervous system, and serosal membranes are affected. SLE owes its inclusion in the heterogeneous group of “rheumatic”diseases to the joint involvement which does not, however, constitute the main focus of the disease. On the other hand, the rheumatic cycle is enriched by SLE, a disease in which there is no doubt about the pathogenetic importance of the autoantibodies which, in other diseases, are often only a doubtful or meaningless epiphenomenon. Typical features of SLE are antinuclear antibodies (ANAs) which occur in 90% of the patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fassbender, H.G. (2002). Systemic Lupus Erythematosus. In: Pathology and Pathobiology of Rheumatic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04819-1_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-04819-1_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-08313-6
Online ISBN: 978-3-662-04819-1
eBook Packages: Springer Book Archive